Nifuratel/Nystatin

硝呋太尔/制霉菌素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameNifuratel/Nystatin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionErgosterol binders
TargetsErgosterol
Therapy Area/IndicationsVaginal infectionTrichomonas InfectionsCandidiasis, Vulvovaginal +[5] 
Global Approved IndicationsVaginosis, Bacterial
Approved Indications in ChinaVaginosis, Bacterial
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes NifuratelNystatin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesZhuzhou Qianjin Pharmaceutical Co LtdJiangsu Wangao Pharmaceutical Co LtdYantai Luyin Pharmaceutical Co Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsVaginal infectionTrichomonas InfectionsCandidiasis, Vulvovaginal +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A